Surgical removal of TdLNs or inhibition of T cell migration through LNs can reduce the response to anti-PD(L)-1 treatment in melanoma mouse models (103, 104), suggesting the presence of lymphoid structures and recirculation of T cells to the tumor sites are crucial for immunotherapies. Here, CD274 is linked to neoplasm.